Streetwise Reports Examines Small-Cap Firm Whose Livestock Feed Antibiotic Replacement Enters Large US Market
March 13, 2019 07:00 ET
|
Streetwise Reports Llc
SAN FRANCISCO, March 13, 2019 (GLOBE NEWSWIRE) -- Canada-based Avivagen Inc.'s (VIV:TSX.V) proprietary OxC-beta™ Livestock premix for livestock feeds is a non-antibiotic means of maintaining optimal...
Streetwise Reports Examines Why This Biotech, Whose Discovery Could End Routine Antibiotic Use in Livestock, Is the Pick of Three Fund Managers
October 31, 2018 07:00 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (VIV:TSX.V), a biotech company focused on science-based, natural health products for livestock, companion animals and humans, is making...